In this study, CDKN1B and CDKN2A polymorphisms were found to contribute 11% of the total risk of developing a sporadic MTC and, when combined with CDKN2C polymorphisms, to be associated with aggressiveness. This evidence concerns the gene CDKN2C and medullary thyroid gland carcinoma.